Views & Analysis Get real: virtual reality for healthcare comes of age After a few false dawns over the years, has virtual reality’s time come?
Views & Analysis Clinical trial summaries for lay people – unpicking the guid... Creating drug trial summaries that the public can understand.
Views & Analysis Harnessing behavioural science for smart communications Behavioural science can be applied to inform and improve outcomes all round.
Views & Analysis Orphan drugs: overcoming barriers to market access What manufacturers should consider, after successfully overcoming any HTA hurdles, to achieve market access.
Views & Analysis Patient personas can help drive behaviour change Creating patient personas from large data sets can drive greater understanding of patients' behaviours.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
